search
Back to results

Low-frequency High-Intensity Interval Training in Overweight or Obese Young Adults

Primary Purpose

Overweight and Obesity

Status
Completed
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Exercise intervention
Sponsored by
The University of Hong Kong
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Overweight and Obesity focused on measuring HIIT, Exercise frequency, Exercise intensity

Eligibility Criteria

18 Years - 30 Years (Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  1. Chinese male
  2. Aged 18-30 years
  3. Overweight or obesity, defined as BMI ≥23 kg/m2 (classification of overweight for Hong Kong adults according to Department of Health, Hong Kong SAR Government)

Exclusion Criteria:

  1. Chronic medical and health condition such as cardiovascular diseases, diabetes, neurological disease, musculoskeletal disorder, cancers, and autoimmune diseases
  2. Hypertension (blood pressure >140/90 mmHg)
  3. Contraindications to participating in physical exercise
  4. Any pre-existing medical or physical issues that affected the experimental test
  5. Physically active (i.e., >3 hours of moderate-intensity exercise weekly)
  6. Lean overweight population (BMI ≥23 kg/m2, but percent body fat ≤20%) according to the BMI data corresponding to bioelectrical impedance estimated percent body fat cut-off value among Hong Kong Chinese adults.

Sites / Locations

  • LKS Faculty of Medicine

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

No Intervention

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

Control

Moderate Intensity Continuous Training ×3/wk

High Intensity Interval Training×3/wk

High Intensity Interval Training×2/wk

High Intensity Interval Training×1/wk

Arm Description

Subjects in this group do not received any intervention

Subjects in this group will receive three sessions of Moderate-Intensity Continuous Training per week throughout the 8 weeks experimental period

Subjects in this group will receive three sessions of High-Intensity Interval Training per week throughout the 8 weeks experimental period

Subjects in this group will receive two session of High-Intensity Interval Training per week throughout the 8 weeks experimental period

Subjects in this group will receive one session of High-Intensity Interval Training per week throughout the 8 weeks experimental period

Outcomes

Primary Outcome Measures

Estimated maximal oxygen consumption
Estimated maximal oxygen consumption achieved during the 20-meter shuttle multistage run test were used for the assessment of aerobic fitness Unit: body weight, estimated oxygen consumption and minute will be combined to report the estimated VO2max in ml/kg/min.
Total running distance
Total running distance in meters achieved during the 20-meter shuttle multistage run test were used for the assessment of aerobic fitness
Total body fat percentage
Total body fat percentage were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Total body fat mass
Total body fat mass in kg were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Total body fat-free mass percentage
Total body fat-free mass percentage were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Total fat-free mass
Total body fat-free mass were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Trunk fat mass
Trunk fat mass in kg were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Body weight
Body weight in kg were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Body height
Body height in meter were assessed.
Body mass index (BMI)
Weight and height will be combined to report BMI in kg/m^2
Waist circumference
Waist circumference was determined to the nearest 0.1 cm of a contact tension tape. The tape was applied directly to the skin at the mid-point between the lower margin of the last palpable rib and the top of the iliac crest.

Secondary Outcome Measures

Systolic blood pressure
Systolic blood pressure was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)
Diastolic blood pressure
Diastolic blood pressure was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)
Mean arterial pressure
Mean arterial pressure was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)
Resting heart rate
Resting heart rate was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)
Endothelial function
Endothelial function were measured by digital plethysmography using EndoPAT 2000 device (ITAMAR Medical, Caesarea, Israel) and expressed as natural log reactive hyperemia index (LnRHI)
Arterial stiffness
Arterial stiffness were measured by digital plethysmography using EndoPAT 2000 device (ITAMAR Medical, Caesarea, Israel) and expressed as augmentation index normalized to heart rate of 75 bpm (AI@75)
Serum fasting glucose
Fresh blood samples were sent to an accredited medical laboratory to measure the serum fasting glucose concentrations by commercial test kit methods with an automatic clinical chemistry analyzer (Architect CI8200, Abbott Diagnostics, USA)
Triglycerides
Fresh blood samples were sent to an accredited medical laboratory to measure the serum triglycerides concentrations by commercial test kit methods with an automatic clinical chemistry analyzer (Architect CI8200, Abbott Diagnostics, USA)
High-density lipoproteins (HDL) cholesterol
Fresh blood samples were sent to an accredited medical laboratory to measure the serum high-density lipoproteins-cholesterol (HDL-C) concentrations by commercial test kit methods with an automatic clinical chemistry analyzer (Architect CI8200, Abbott Diagnostics, USA)
Low-density lipoprotein (LDL) cholesterol
Low-density lipoprotein (LDL) cholesterol in serum was measured by an automatic chemistry analyzer (AU-480, Beckman Coulter, USA)
Interleukin 6
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine interleukin 6
Tumor necrosis factor alpha
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine tumor necrosis factor alpha
C-reactive protein
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine c-reactive protein
Adiponectin
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine adiponectin
Intercellular adhesion molecule-1
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine intercellular adhesion molecule-1
Vascular cell adhesion molecule-1
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine vascular cell adhesion molecule-1

Full Information

First Posted
March 31, 2019
Last Updated
April 3, 2019
Sponsor
The University of Hong Kong
search

1. Study Identification

Unique Protocol Identification Number
NCT03904810
Brief Title
Low-frequency High-Intensity Interval Training in Overweight or Obese Young Adults
Official Title
The Effectiveness of Low-frequency High-Intensity Interval Training (HIIT) in Overweight or Obese Young Adults
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
October 1, 2016 (Actual)
Primary Completion Date
August 31, 2017 (Actual)
Study Completion Date
August 31, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The University of Hong Kong

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: The relationship between the frequency of high-intensity interval training (HIIT) and the resultant adaptations is largely unclear. Purpose: This study examined the effects of different frequencies of HIIT compared to moderate-intensity continuous training (MICT) on body composition and cardiovascular biomarkers in overweight or obese adults. Methods: This study was a randomized, controlled, single-blinded trial. Fifty-six overweight or obese men aged between 18 and 30 years were randomly assigned to no-intervention control (CON; n=14), MICT performed thrice weekly (MICT×3/wk; n=9), HIIT performed thrice weekly (HIIT×3/wk; n=14), HIIT performed twice weekly (HIIT×2/wk; n=10), and HIIT performed once weekly (HIIT×1/wk; n=9). Each HIIT session consisted of 12 × 1-min bouts at 90% heart rate reserve (HRR), interspersed with 11 × 1-min bouts at 70% HRR (HIIT×3/wk: 69 min/wk; HIIT×2/wk: 46 min/wk; HIIT×1/wk: 23 min/wk). Aerobic capacity, resting heart rate, body composition, waist circumference, blood pressure, endothelial function, fasting blood glucose and lipids, circulatory adipokines and inflammatory biomarkers were examined at baseline, after 4 weeks and 8 weeks of intervention.
Detailed Description
Individuals who fulfilled the following inclusion criteria were invited to participate in the present study: 1) Chinese male; 2) aged 18-30 years; and 3) overweight or obesity, defined as BMI ≥23 kg/m2 (classification of overweight for Hong Kong adults according to Department of Health, Hong Kong SAR Government) (13). Subjects were excluded if they had: 1) chronic medical and health condition such as cardiovascular diseases, diabetes, neurological disease, musculoskeletal disorder, cancers, and autoimmune diseases; 2) hypertension (blood pressure >140/90 mmHg); 3) contraindications to participating in physical exercise; 4) any pre-existing medical or physical issues that affected the experimental test; 5) physically active (i.e., >3 hours of moderate-intensity exercise weekly) or 6) lean overweight population (BMI ≥23 kg/m2, but percent body fat ≤20%) according to the BMI data corresponding to bioelectrical impedance estimated percent body fat cut-off value among Hong Kong Chinese adults. Of those who were screened, 103 Chinese young adults were eligible to participate in this study. They were provided with written and verbal information on the study protocol and the possible associated discomforts and risks followed by obtaining their written informed consent to participate in this study. The study protocol and consent form were approved by the Human Subjects Ethics Sub-Committee of The Hong Kong Polytechnic University (ethics approval reference number: HSEARS20160927005-01). This study was a single-blind, randomized, controlled trial. Subjects were randomly assigned to 1) no-intervention control (CON), 2) MICT performed thrice weekly (MICTx3/wk), 3) HIIT performed thrice weekly (HIITx3/wk), 4) twice weekly (HIITx2/wk), and 5) once weekly (HIITx1/wk). All subjects were instructed to maintain their usual daily activities. Outcome measures including aerobic capacity, body composition, blood pressure, resting heart rate, endothelial function, arterial stiffness, fasting glucose, lipids markers, adipokine marker, and inflammatory marker were assessed at baseline, 4 weeks and 8 weeks after the intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight and Obesity
Keywords
HIIT, Exercise frequency, Exercise intensity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
5 groups ×3 times factorial design
Masking
Participant
Allocation
Randomized
Enrollment
103 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Subjects in this group do not received any intervention
Arm Title
Moderate Intensity Continuous Training ×3/wk
Arm Type
Active Comparator
Arm Description
Subjects in this group will receive three sessions of Moderate-Intensity Continuous Training per week throughout the 8 weeks experimental period
Arm Title
High Intensity Interval Training×3/wk
Arm Type
Active Comparator
Arm Description
Subjects in this group will receive three sessions of High-Intensity Interval Training per week throughout the 8 weeks experimental period
Arm Title
High Intensity Interval Training×2/wk
Arm Type
Active Comparator
Arm Description
Subjects in this group will receive two session of High-Intensity Interval Training per week throughout the 8 weeks experimental period
Arm Title
High Intensity Interval Training×1/wk
Arm Type
Active Comparator
Arm Description
Subjects in this group will receive one session of High-Intensity Interval Training per week throughout the 8 weeks experimental period
Intervention Type
Behavioral
Intervention Name(s)
Exercise intervention
Intervention Description
HIIT groups performed 30-meter shuttle runs on a rooftop covered field whereas MICT group ran on a footpath with an overall flat and non-slippery road surface. All training sessions were preceded by a 5-minute self-pace warm-up jogging and ended with a 5-minute self-pace jogging or walking cool-down. Each session of MICT consisted of 30 minutes of continuous exercise at an intensity of 60% of heart rate reserve (HRR); [i.e., (maximal HR - resting HR) × intensity + resting HR]. For each HIIT session, the intensity was set at 90% HRR for high-intensity bouts, interspersed with active recovery at 70% HRR. All exercise sessions were supervised by qualified athletic coach or strength and conditioning coach.
Primary Outcome Measure Information:
Title
Estimated maximal oxygen consumption
Description
Estimated maximal oxygen consumption achieved during the 20-meter shuttle multistage run test were used for the assessment of aerobic fitness Unit: body weight, estimated oxygen consumption and minute will be combined to report the estimated VO2max in ml/kg/min.
Time Frame
8 weeks
Title
Total running distance
Description
Total running distance in meters achieved during the 20-meter shuttle multistage run test were used for the assessment of aerobic fitness
Time Frame
8 weeks
Title
Total body fat percentage
Description
Total body fat percentage were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Time Frame
8 weeks
Title
Total body fat mass
Description
Total body fat mass in kg were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Time Frame
8 weeks
Title
Total body fat-free mass percentage
Description
Total body fat-free mass percentage were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Time Frame
8 weeks
Title
Total fat-free mass
Description
Total body fat-free mass were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Time Frame
8 weeks
Title
Trunk fat mass
Description
Trunk fat mass in kg were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Time Frame
8 weeks
Title
Body weight
Description
Body weight in kg were assessed by a bioelectrical impedance analyzer (BC-418, Tanita, Japan).
Time Frame
8 weeks
Title
Body height
Description
Body height in meter were assessed.
Time Frame
8 weeks
Title
Body mass index (BMI)
Description
Weight and height will be combined to report BMI in kg/m^2
Time Frame
8 weeks
Title
Waist circumference
Description
Waist circumference was determined to the nearest 0.1 cm of a contact tension tape. The tape was applied directly to the skin at the mid-point between the lower margin of the last palpable rib and the top of the iliac crest.
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Systolic blood pressure
Description
Systolic blood pressure was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)
Time Frame
8 weeks
Title
Diastolic blood pressure
Description
Diastolic blood pressure was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)
Time Frame
8 weeks
Title
Mean arterial pressure
Description
Mean arterial pressure was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)
Time Frame
8 weeks
Title
Resting heart rate
Description
Resting heart rate was determined by an electronic sphygmomanometer (Accutorr Plus, Datascope, USA)
Time Frame
8 weeks
Title
Endothelial function
Description
Endothelial function were measured by digital plethysmography using EndoPAT 2000 device (ITAMAR Medical, Caesarea, Israel) and expressed as natural log reactive hyperemia index (LnRHI)
Time Frame
8 weeks
Title
Arterial stiffness
Description
Arterial stiffness were measured by digital plethysmography using EndoPAT 2000 device (ITAMAR Medical, Caesarea, Israel) and expressed as augmentation index normalized to heart rate of 75 bpm (AI@75)
Time Frame
8 weeks
Title
Serum fasting glucose
Description
Fresh blood samples were sent to an accredited medical laboratory to measure the serum fasting glucose concentrations by commercial test kit methods with an automatic clinical chemistry analyzer (Architect CI8200, Abbott Diagnostics, USA)
Time Frame
8 weeks
Title
Triglycerides
Description
Fresh blood samples were sent to an accredited medical laboratory to measure the serum triglycerides concentrations by commercial test kit methods with an automatic clinical chemistry analyzer (Architect CI8200, Abbott Diagnostics, USA)
Time Frame
8 weeks
Title
High-density lipoproteins (HDL) cholesterol
Description
Fresh blood samples were sent to an accredited medical laboratory to measure the serum high-density lipoproteins-cholesterol (HDL-C) concentrations by commercial test kit methods with an automatic clinical chemistry analyzer (Architect CI8200, Abbott Diagnostics, USA)
Time Frame
8 weeks
Title
Low-density lipoprotein (LDL) cholesterol
Description
Low-density lipoprotein (LDL) cholesterol in serum was measured by an automatic chemistry analyzer (AU-480, Beckman Coulter, USA)
Time Frame
8 weeks
Title
Interleukin 6
Description
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine interleukin 6
Time Frame
8 weeks
Title
Tumor necrosis factor alpha
Description
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine tumor necrosis factor alpha
Time Frame
8 weeks
Title
C-reactive protein
Description
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine c-reactive protein
Time Frame
8 weeks
Title
Adiponectin
Description
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine adiponectin
Time Frame
8 weeks
Title
Intercellular adhesion molecule-1
Description
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine intercellular adhesion molecule-1
Time Frame
8 weeks
Title
Vascular cell adhesion molecule-1
Description
Commercially available enzyme-linked immunosorbent assay kits (R&D systems, Minneapolis, MN) were used to determine vascular cell adhesion molecule-1
Time Frame
8 weeks

10. Eligibility

Sex
Male
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chinese male Aged 18-30 years Overweight or obesity, defined as BMI ≥23 kg/m2 (classification of overweight for Hong Kong adults according to Department of Health, Hong Kong SAR Government) Exclusion Criteria: Chronic medical and health condition such as cardiovascular diseases, diabetes, neurological disease, musculoskeletal disorder, cancers, and autoimmune diseases Hypertension (blood pressure >140/90 mmHg) Contraindications to participating in physical exercise Any pre-existing medical or physical issues that affected the experimental test Physically active (i.e., >3 hours of moderate-intensity exercise weekly) Lean overweight population (BMI ≥23 kg/m2, but percent body fat ≤20%) according to the BMI data corresponding to bioelectrical impedance estimated percent body fat cut-off value among Hong Kong Chinese adults.
Facility Information:
Facility Name
LKS Faculty of Medicine
City
Hong Kong
Country
Hong Kong

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Low-frequency High-Intensity Interval Training in Overweight or Obese Young Adults

We'll reach out to this number within 24 hrs